Where does Argos Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Argos Therapeutics, Inc. ranks #18,395 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Argos Therapeutics, Inc. hold?

Argos Therapeutics, Inc. holds 15 US utility patents granted between 2015 and 2019, spanning 10 technology areas.

What is Argos Therapeutics, Inc.'s Innovation Score?

Argos Therapeutics, Inc. has an Innovation Score of 30.0 out of 100 (33rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Argos Therapeutics, Inc. focus on?

Argos Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 8 patents, ranking #2,696 of 7,163 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Argos Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Argos Therapeutics, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Argos Therapeutics, Inc.'s patents?

Argos Therapeutics, Inc.'s patents average 15.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Argos Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Argos Therapeutics, Inc.

USPTO PatentsView assignee record - 15 granted patents across 10 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Argos ranks #18,395 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 10 technology areas.

#18,395
of 49,997 US assignees by volume: 33rd percentile
by Innovation Score (30.0/100): 15.5
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18395 · US Corporation #18,395 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,395/49,997
PHOTO-FINISH Ao Jie Plastic Toys…
CPC-FOCUS A61K · 10 areas
INNOV-THIN 30.0/100
CLAIMS-RICH 15.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ao Jie Plastic Toys Factory Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Argos’s 30.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (32%) Velocity 0.0 pts (0%) Breadth 11.2 pts (37%) Claim depth 9.3 pts (31%)

Qualcomm Incorporated · highest

85
Argos Therapeutics · this assignee

30
3D Lighting… · lowest

7

What this shows Argos's Innovation Score is 30.0/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Argos?

Each dot is one of Argos’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Argos’s own 15.5 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Argos vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Argos's grants concentrate

Argos Therapeutics, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 53.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2019. By volume, Argos sits between Ao Jie Plastic Toys Factory Ltd. and Aspen Medical Partners, LLC.

Ao Jie Plastic To…

15
Apeiron Synthesis

15
Aptar Freyung

15
Arcscan

15
Ariadne's Thread…

15
Arjo IP Holding AB

15
Asator Global

15
Aspen Medical Par…

15
Argos Therapeutics ◀

15

What this shows Argos holds 15 patents at rank #18,409, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Argos

By rank, the assignees closest to #18,409 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Argos's primary technology class.

Argos's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Argos Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	20.0%
2016	4	26.7%
2017	3	20.0%
2018	4	26.7%
2019	1	6.7%

Which technologies does Argos Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 5

C07K - Peptides 4

G01L - Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, OR Fluid Pressure 4

Y10T - Technical Subjects Covered BY Former US Classification 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

B04B - Centrifuges 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Argos Therapeutics, Inc.'s patent record in context - here's where to go next.

Argos Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 53.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #18,395 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Argos Therapeutics, Inc. against Ao Jie Plastic Toys Factory Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.